These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2137932)

  • 21. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
    Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
    Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elutriation of bone marrow delineates two distinct natural suppressor cell populations.
    Noga SJ; Fischer AC; Horwitz LR; Donnenberg AD; Wagner JE; Hess AD
    Prog Clin Biol Res; 1990; 333():363-8. PubMed ID: 2137933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
    Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
    Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
    Min CK; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 May; 27(9):999-1005. PubMed ID: 11436112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
    Marciniak E; Romond EH; Thompson JS; Henslee PJ
    Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
    Wawer A; Laws HJ; Dilloo D; Göbel U; Burdach S
    Klin Padiatr; 2004; 216(3):169-75. PubMed ID: 15175962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.
    Wagner JE; Donnenberg AD; Noga SJ; Cremo CA; Gao IK; Yin HJ; Vogelsang GB; Rowley S; Saral R; Santos GW
    Blood; 1988 Oct; 72(4):1168-76. PubMed ID: 3048436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation].
    Merino A; Urbano-Ispizua A; Marín P; Besson I; Carreras E; Sierra J; Salgado C; Rovira M; Grañena A; Montserrat E
    Sangre (Barc); 1993 Oct; 38(5):359-64. PubMed ID: 8140496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.
    McDonough CH; Jacobsohn DA; Vogelsang GB; Noga SJ; Chen AR
    Bone Marrow Transplant; 2003 Jun; 31(12):1073-80. PubMed ID: 12796786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation.
    de Witte T; Hoogenhout J; de Pauw B; Holdrinet R; Janssen J; Wessels J; van Daal W; Hustinx T; Haanen C
    Blood; 1986 May; 67(5):1302-8. PubMed ID: 3516253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow.
    Noga SJ; Donnenberg AD; Schwartz CL; Strauss LC; Civin CI; Santos GW
    Transplantation; 1986 Feb; 41(2):220-9. PubMed ID: 2935979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale separation of human bone marrow by counterflow centrifugation elutriation.
    Noga SJ; Cremo CA; Duff SC; Schwartz CL; Melaragno A; Civin CI; Donnenberg AD
    J Immunol Methods; 1986 Sep; 92(2):211-8. PubMed ID: 2944969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of T-cell depletion in HLA matched bone marrow transplantation.
    Gilmore MJ; Patterson J; Ivory K; Brenner MK; Graphakos S; Janossy G; Hoffbrand AV; Prentice HG
    Br J Haematol; 1986 Sep; 64(1):69-75. PubMed ID: 3530316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
    Ho VT; Soiffer RJ
    Blood; 2001 Dec; 98(12):3192-204. PubMed ID: 11719354
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of the natural suppressor cell population in adult rat bone marrow.
    Noga SJ; Wagner JE; Horwitz LR; Donnenberg AD; Santos GW; Hess AD
    J Leukoc Biol; 1988 Mar; 43(3):279-87. PubMed ID: 2963882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.